Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, May 14, 2021
[ Fri, May 14th 2021
] - WOPRAI
[ Fri, May 14th 2021
] - WOPRAI
[ Fri, May 14th 2021
] - WOPRAI
[ Fri, May 14th 2021
] - WOPRAI
[ Fri, May 14th 2021
] - WOPRAI
[ Fri, May 14th 2021
] - WOPRAI
[ Fri, May 14th 2021
] - WOPRAI
[ Fri, May 14th 2021
] - WOPRAI
[ Fri, May 14th 2021
] - WOPRAI
[ Fri, May 14th 2021
] - WOPRAI
[ Fri, May 14th 2021
] - WOPRAI
[ Fri, May 14th 2021
] - WOPRAI
[ Fri, May 14th 2021
] - WOPRAI
[ Fri, May 14th 2021
] - WOPRAI
Thu, May 13, 2021
[ Thu, May 13th 2021
] - WOPRAI
[ Thu, May 13th 2021
] - WOPRAI
[ Thu, May 13th 2021
] - WOPRAI
[ Thu, May 13th 2021
] - WOPRAI
[ Thu, May 13th 2021
] - WOPRAI
[ Thu, May 13th 2021
] - WOPRAI
[ Thu, May 13th 2021
] - WOPRAI
[ Thu, May 13th 2021
] - WOPRAI
[ Thu, May 13th 2021
] - WOPRAI
[ Thu, May 13th 2021
] - WOPRAI
[ Thu, May 13th 2021
] - WOPRAI
[ Thu, May 13th 2021
] - WOPRAI
[ Thu, May 13th 2021
] - WOPRAI
[ Thu, May 13th 2021
] - WOPRAI
[ Thu, May 13th 2021
] - WOPRAI
Anupam Rama Upgraded (ATRA) to Buy and Increased Target to $725 on, May 13th, 2021
Anupam Rama of JP Morgan, Upgraded "Atara Biotherapeutics, Inc." (ATRA) to Buy and Increased Target from $575 to $725 on, May 13th, 2021.
Anupam has made no other calls on ATRA in the last 4 months.
There is 1 other peer that has a rating on ATRA. Out of the 1 peers that are also analyzing ATRA, 0 agree with Anupam's Rating of Hold.
This is the rating of the analyst that currently disagrees with Anupam
- Robert Burns of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $775 on, Wednesday, May 5th, 2021
